The prevalence of borderline personality among buprenorphine patients

International Journal of Psychiatry in Medicine

Volumn 38, Issue 2, 2008, Pages 217-226

  Sansone, Randy A ^a,c   Phillip Whitecar, M D ^a   Wiederman, Michael W ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b Mathematics and Sciences   (United States)

^c Sycamore Primary Care Center   (United States)

Author keywords

Borderline personality; Buprenorphine; Opiates; Substance dependence

Indexed keywords

BUPRENORPHINE;

ADULT; ARTICLE; BORDERLINE STATE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTPATIENT CARE; PREVALENCE; QUESTIONNAIRE; SELF REPORT;

ADOLESCENT; ADULT; BORDERLINE PERSONALITY DISORDER; BUPRENORPHINE; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PERSONALITY INVENTORY; SUBSTANCE ABUSE TREATMENT CENTERS; YOUNG ADULT;

EID: 57749184616     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.38.2.h     Document Type: Article

References (36)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th Edition, text revision). Washington, DC: Author, 2000.
2. Prasad RB, Val ER, Lahmeyer HW, Gaviria M, Rodgers P, Weiler M, et al. Associated diagnoses (comorbidity) in patients with borderline personality disorder. Psychiatric Journal of the University of Ottawa 1990;15:22-27.
3. McGlashan TH, Grilo CM, Skodol AE, Gunderson JG, Shea MT, Morey LC, et al. The collaborative longitudinal personality disorders study: Baseline Axis I/II and II/II diagnostic co-occurrence. Acta Psychiatrica Scandinavica 2000;102:256-264.
4. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, et al. Axis I comorbidity of borderline personality disorder. American Journal of Psychiatry 1998;155:1733-1739.
5. Miller FT, Abrams T, Dulit R, Fyer M. Substance abuse in borderline personality disorder. American Journal of Drug and Alcohol Abuse 1993;19:491-497.
6. Links PS, Heslegrave RJ, Mitton JE, Van Reekum R, Patrick J. Borderline personality disorder and substance abuse: Consequences of comorbidity. Canadian Journal of Psychiatry 1995;40:9-14.
7. Sansone RA, Songer DA, Miller KA. Childhood abuse, mental healthcare utilization, self-harm behavior, and multiple psychiatric diagnoses among inpatients with and without a borderline diagnosis. Comprehensive Psychiatry 2005;46:117-120.
8. Grilo CM, Martino S, Walker ML, Becker DF, Edell WS, McGlashan TH. Controlled study of psychiatric comorbidity in psychiatrically hospitalized young adults with substance use disorders. American Journal of Psychiatry 1997;154:1305-1307.
9. Skinstad AH, Swain A. Comorbidity in a clinical sample of substance abusers. American Journal of Drug and Alcohol Abuse 2001;27:45-64.
10. Darke S, Ross J, Williamson A, Teesson M. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence. Addiction 2005;100:1121-1130.
11. Dulit RA, Fyer MR, Haas GL, Sullivan T, Frances AJ. Substance use in borderline personality disorder. American Journal of Psychiatry 1990;147:1002-1007.
12. Hatzitaskos P, Soldatos CR, Kokkevi A, Stefanis CN. Substance abuse patterns and their association with psychopathology and type of hostility in male patients with borderline and antisocial personality disorder. Comprehensive Psychiatry 1999;40:278-282.
13. Thomas VH. Personality disorders and substance abuse: Patterns of comorbidity in an inpatient treatment population. Dissertation Abstracts International 1996;56:7081B.
14. Frankenburg FR, Zanarini MC. The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. Journal of Clinical Psychiatry 2004;65:1660-1665.
15. Kaplan MA, Korelitz BI. Narcotic dependence in inflammatory bowel disease. Journal of Clinical Gastroenterology 1998;10:275-278.
16. Zeeck A, Birindelli E, Sandholz A, Joos A, Herzog T, Hartmann A. Symptom severity and treatment course of bulimic patients with and without a borderline personality disorder. European Eating Disorders Review 2007;15:430-438.
17. Bellino S, Patria L, Paradiso E, Di Lorenzo R, Zanon C, Zizza M, et al. Major depression in patients with borderline personality disorder: A clinical investigation. Canadian Journal of Psychiatry 2005;50:234-238.
18. Ozkan M, Altindag A. Comorbid personality disorders in subjects with panic disorder: Do personality disorders increase clinical severity? Comprehensive Psychiatry 2005;46:20-26.
19. Skodol AE, Grilo CM, Pagano ME, Bender DS, Gunderson JG, et al. Effects of personality disorders on functioning and well-being in major depressive disorder. Journal of Psychiatric Practice 2005;11:363-368.
20. Ilardi SS, Craighead WE, Evans DD. Modeling relapse in unipolar depression: The effects of dysfunctional cognitions and personality disorders. Journal of Consulting and Clinical Psychology 1997;65:381-391.
21. Baer L, Janike MA, Black DW, Treece C, Rosenfeld R, Greist J. Effects of Axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Archives of General Psychiatry 1992;49:862-866.
22. Ames-Frankel J, Devlin MJ, Walsh BT, Strasser TJ, Sadik C, Oldham JM, et al. Personality disorder diagnoses in patients with bulimia nervosa: Clinical correlates and changes with treatment. Journal of Clinical Psychiatry 1992;53:90-96.
23. Verhuel R, vandenBrink W, Hartgers C. Personality disorders predict relapse in alcoholic patients. Addictive Behavior 1998;23:869-882.
24. Sansone RA, Sansone LA. Borderline personality in the medical setting. New York: Nova Science Publishers, 2007.
25. Feske U, Mulsant BH, Pilkonis PA, Soloff P, Dolata D, Sackeim HA, et al. Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. American Journal of Psychiatry 2004;161:2073-2080.
26. Sansone RA, Songer DA, Miller KA. Childhood abuse, mental healthcare utilization, self-harm behavior, and multiple psychiatric diagnoses among inpatients with and without a borderline diagnosis. Comprehensive Psychiatry 2005;46:117-120.
27. Black DW, Blum N, Pfohl B, Hale N. Suicidal behavior in borderline personality disorder: Prevalence, risk factors, prediction, and prevention. Journal of Personality Disorders 2004;18:226-239.
28. Hyler SE. Personality Diagnostic Questionnaire-4. New York State Psychiatric Institute: Author, 1994.
29. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th Edition). Washington, DC: Author, 1994.
30. Dubro AF, Wetzler S, Kahn MW. A comparison of three self-report questionnaires for the diagnosis of DSM-III personality disorders. Journal of Personality Disorders 1988;2:256-266.
31. Hyler SE, Lyons M, Rieder RO, Young L, Williams JBW, Spitzer RL. The factor structure of self-report DSM-III Axis II symptoms and their relationship to clinicians' ratings. American Journal of Psychiatry 1990;147:751-757.
32. Johnson JG, Bornstein RF. Utility of the Personality Diagnostic Questionnaire-Revised in a nonclinical sample. Journal of Personality Disorders 1992;6:450-457.
33. Patrick J, Links P, Van Reekum R, Mitton MJE. Using the PDQ-R BPD scale as a brief screening measure in the differential diagnosis of personality disorder. Journal of Personality Disorders 1995;9:266-274.
34. Sansone RA, Wiederman MW, Sansone LA. The Self-Harm Inventory (SHI): Development of a scale for identifying self-destructive behaviors and borderline personality disorder. Journal of Clinical Psychology 1998;54:973-983.
35. Kolb JE, Gunderson JG. Diagnosing borderline patients with a semi-structured interview. Archives of General Psychiatry 1980;37:37-41.
36. Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. A screening measure for BPD: The McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). Journal of Personality Disorders 2003;17:568-573.